By growing “mini-livers” from adult mouse stem cells, the road may be paved to replacing, reducing or refining the use of animals in science.
Dr. Meritxell Huch from the Gurdon Institute at Cambridge received the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) 3Rs Prize for developing a method that enables adult mouse stem cells to grow and expand into fully functioning three-dimensional liver tissue.
Using this method, cells from one mouse could be used to test 1,000 drug compounds to treat liver disease, and reduce animal use by up to 50,000. Growing hepatocytes (liver cells) in the laboratory has been attempted by liver biologists for many years, since it would reduce their reliance on using mice to study liver disease and would open up new opportunities in medical research and drug safety testing.
Until then, no laboratory had been successful in deciphering how to isolate and grow these cells. Liver stem cells are typically found in a dormant state in the liver, only becoming active following injury to produce new liver cells and bile ducts.
Huch and colleagues at the Netherlands’ Hubrecht Institute located the specific type of stem cells responsible for this regeneration, which are recognised by a key surface protein (Lgr5+) that they share with similar stem cells in the intestine, stomach and hair follicles. By isolating these cells and placing them in a culture medium with the right conditions, the researchers were able to grow small liver organoids, which survive and expand for over a year in a laboratory environment. When implanted back into mice with liver disease they continued to grow, ameliorating the disease and extending the survival of the mice.
Having further refined the process using cells from rats and dogs, Huch is now moving onto testing it with human cells, which could potentially translate to the development of a patient’s own liver tissue for transplantation.
Commenting on the new method’s potential to reduce animal use in liver research, Huch said, “Typically a study to investigate one potential drug compound to treat one form of liver disease would require up to 50 live animals per experiment, so testing 1000 compounds would need 50,000 mice. By using the liver culture system I developed, we can test 1000 compounds using cells that come from only one mouse, resulting in a significant reduction in animal use. If other laboratories adopt this method then the impact on animal use in the liver research field would be immediate. A vast library of potential drug compounds could be narrowed down to just one or two very quickly and cheaply, which can then be tested further in an animal study.”
Dr Vicky Robinson, Chief Executive of the NC3Rs said, “Growing functioning liver cells in culture has been the Holy Grail for liver biologists for many years, so a limitless supply of hepatocytes could have a huge 3Rs impact both on basic research to understand liver disease and for the screening and safety testing of pharmaceuticals. Researchers need to utilise this alternative technology as soon as possible to ensure the benefits to animals and human health are fully realized.”
Source: University of Cambridge
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Greenpeace Says Its GMOs Are Better Than Science's GMOs, Still Hates Golden Rice
- Reduce Prostate Cancer Risk By Sleeping With Lots Of Women - But Not Men
- Homo Floresiensis: Hobbit Species Continues To Provoke Questions About Human Evolution
- Supersonic Laser-Propelled Aircraft Get A Step Closer
- Okay With Disgusting Images? You Vote This Way 95 Percent Of The Time
- Everyone Hates Daylight Savings Time - But It Might Improve Public Health
- This Mid-Term Election Can Have Evolutionary Consequences
- "You, and Greenpeace, are doing just that. GMO is a legal definition, not a science one, and that..."
- "We lack new medicines because the patents expire too quickly and the regulatory burden is too high..."
- "The problem is, American agricultural science cannot be adopted world-wide for the simple reason..."
- "You're quote mining. When it comes to environmental risk, energy emissions from CO2 are back at..."
- "Of course they aren't. These are scientific terms Hank Campbell and you can't just interpret them..."
- Battle of Britain: NGOs and scientists clash over proposal to loosen EU GMO restrictions
- Genetically modified clean energy from bacteria
- Designer babies: You can screen for cystic fibrosis but intelligence is a ways off
- Science as profane: What superstition of 1752 and 2014 share in common
- What’s so “natural” about “natural crop breeding”?
- Worried you have cancer? Take a Google pill!
- CHEST lung cancer experts present policy statement to CMS Committee on Coverage
- Clinical practice guidelines address multimodality treatment for esophageal cancer
- Molecular tumor markers could reveal new therapeutic targets for lung cancer treatment
- Breakdown in gut barriers to bacteria may promote inflammation and craving in alcoholics
- Sadness lasts longer than other emotions